FDA Issues Moderna a 75% Refund - Refuses to Review License Application for New mRNA Flu Vaccine

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts

FDA Issues Moderna a 75% Refund - Refuses to Review License Application for New mRNA Flu Vaccine

The FDA refused to review Moderna’s license application for the mRNA flu vaccine because its safety and efficacy was compared to a currently licensed flu vaccine as the control group.

This post is for paid subscribers